POINT Biopharma Coming to Indianapolis

Canada-based POINT Biopharma will establish its first U.S. manufacturing facility in Indianapolis. The company plans to invest more than $25 million to purchase and renovate a 77,000 square foot building on the city’s northwest side. The deal will create more than 100 new jobs by the end of 2024. POINT Biopharma CEO Joe McCann joins us to explain what attracted the company to set up shop in Indiana.

Get the best of Indiana business news. ONLY $1/week Subscribe Now

One Subscription, Unlimited Access to IBJ and Inside INdiana Business Subscribe Now

One Subscription, Unlimited Access to IBJ and Inside INdiana Business Upgrade Now

One Subscription, Unlmited Access to IBJ and Inside INdiana Business Upgrade Now

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Get the best of Indiana business news.

Limited-time introductory offer for new subscribers

ONLY $1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In